Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-24

Clinical Trial Update: Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing safety and efficacy of hypofractionated radiotherapy combined with androgen deprivation therapy for prostate cancer, across Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androgen deprivation therapy (Androgen deprivation therapy)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN